• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    2/3/22 10:49:49 AM ET
    $ALPN
    $AMPS
    $ANIK
    $AXU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $ALPN alert in real time by email

     

     

    On Thursday, 105 stocks hit new 52-week lows.

    Interesting Highlights From Today's 52-Week Lows And Highs:

    • Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Meta Platforms (NASDAQ:FB)'s stock traded down the lowest, falling 23.97% to reach a new 52-week low.
    • Tabula Rasa HealthCare (NASDAQ:TRHC)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low.

    Here is a list of stocks that set new 52-week lows on Thursday:

    • Meta Platforms (NASDAQ:FB) shares set a new 52-week low of $237.07. The stock traded down 23.97%.
    • Honeywell International (NASDAQ:HON) stock drifted down 5.97% on Thursday morning to hit a new 52-week low of $194.17.
    • Snap (NYSE:SNAP) shares set a new yearly low of $25.52 this morning. The stock was down 18.65% on the session.
    • Biogen (NASDAQ:BIIB) shares set a new yearly low of $212.57 this morning. The stock was down 2.66% on the session.
    • Etsy (NASDAQ:ETSY) shares reached a new 52-week low of $128.65 on Thursday morning, moving down 5.16%.
    • Lennox International (NYSE:LII) stock hit a yearly low of $265.20. The stock was down 0.98% for the day.
    • PagSeguro Digital (NYSE:PAGS) shares were down 7.15% for the day, having made a 52-week low of $18.47.
    • Iridium Communications (NASDAQ:IRDM) stock achieved a new 52-week low on Thursday morning, hitting $32.76 and moving down 3.01%.
    • StoneCo (NASDAQ:STNE) shares made a new 52-week low of $13.01 on Thursday. The stock was down 5.92% for the day.
    • Viasat (NASDAQ:VSAT) stock drifted down 0.92% on Thursday morning to hit a new 52-week low of $40.15.
    • Rent-A-Center (NASDAQ:RCII) shares made a new 52-week low of $39.13 on Thursday. The stock was down 1.55% for the day.
    • NOVONIX (NASDAQ:NVX) stock hit a new 52-week low of $18.22. The stock was down 18.11% on the session.
    • Nuveen Municipal Value (NYSE:NUV) shares moved down 1.09% on Thursday to hit a new 52-week low of $9.91, drifting down 1.09%.
    • Renewable Energy Gr (NASDAQ:REGI) stock broke to a new 52-week low of $37.52 on Thursday. Shares of the company traded down 1.15%.
    • Cimpress (NASDAQ:CMPR) stock broke to a new 52-week low of $63.92 on Thursday. Shares of the company traded down 0.43%.
    • Skillz (NYSE:SKLZ) stock achieved a new 52-week low on Thursday morning, hitting $3.91 and moving down 3.03%.
    • PJT Partners (NYSE:PJT) shares fell to $62.30 on Thursday, setting a new 52-week low with a shift of down 0.81%.
    • Sana Biotechnology (NASDAQ:SANA) shares hit a yearly low of $7.65. The stock was down 3.01% on the session.
    • BrightView Holdings (NYSE:BV) stock dropped to a yearly low on Thursday of $12.11. Shares traded down 6.97%.
    • Vacasa (NASDAQ:VCSA) shares made a new 52-week low of $5.56 on Thursday. The stock was down 5.25% for the day.
    • Altus Power (NYSE:AMPS) stock set a new 52-week low of $6.41 on Thursday, moving down 0.23%.
    • Rover Group (NASDAQ:ROVR) shares set a new 52-week low of $4.97. The stock traded down 6.45%.
    • ESS Tech (NYSE:GWH) shares fell to $4.85 on Thursday, setting a new 52-week low with a shift of down 5.72%.
    • FIRST TRUST HIGH YIELD (NYSE:FTHY) shares set a new 52-week low of $18.85. The stock traded down 0.65%.
    • Ventyx Biosciences (NASDAQ:VTYX) stock drifted down 5.88% on Thursday morning to hit a new 52-week low of $13.38.
    • Cardiovascular Systems (NASDAQ:CSII) stock set a new 52-week low of $15.22 on Thursday, moving down 3.59%.
    • Stoke Therapeutics (NASDAQ:STOK) shares were down 3.72% for the day, having made a 52-week low of $16.96.
    • Surmodics (NASDAQ:SRDX) stock hit $36.24 on Thursday morning, setting a new 52-week low for a change of down 11.25%.
    • Blackrock Munivest Fund (NYSE:MVF) shares were down 0.9% for the day, having made a 52-week low of $8.75.
    • Western Asset Managed (NYSE:MMU) stock drifted down 1.05% on Thursday morning to hit a new 52-week low of $12.21.
    • Benson Hill (NYSE:BHIL) stock drifted down 2.68% on Thursday morning to hit a new 52-week low of $2.88.
    • eHealth (NASDAQ:EHTH) stock hit a new 52-week low of $19.22. The stock was down 6.03% on the session.
    • Stoneridge (NYSE:SRI) stock set a new 52-week low of $17.49 on Thursday, moving down 0.95%.
    • Barrett Business Services (NASDAQ:BBSI) shares made a new 52-week low of $62.71 on Thursday. The stock was down 1.62% for the day.
    • Precigen (NASDAQ:PGEN) shares moved down 2.79% on Thursday to hit a new 52-week low of $2.25, drifting down 2.79%.
    • UWM Holdings (NYSE:UWMC) stock achieved a new 52-week low on Thursday morning, hitting $4.41 and moving down 6.05%.
    • Anika Therapeutics (NASDAQ:ANIK) stock hit a new 52-week low of $30.08. The stock was up 0.66% on the session.
    • Kinnate Biopharma (NASDAQ:KNTE) stock hit a yearly low of $9.74. The stock was down 1.3% for the day.
    • Maxeon Solar Technologies (NASDAQ:MAXN) stock set a new 52-week low of $9.11 on Thursday, moving down 3.81%.
    • Citi Trends (NASDAQ:CTRN) stock achieved a new 52-week low on Thursday morning, hitting $44.89 and moving down 6.22%.
    • Spero Therapeutics (NASDAQ:SPRO) shares reached a new 52-week low of $10.52 on Thursday morning, moving down 1.67%.
    • BioAtla (NASDAQ:BCAB) shares set a new 52-week low of $8.36. The stock traded up 1.06%.
    • Sky Harbour Group (AMEX:SKYH) stock hit a new 52-week low of $5.39. The stock was down 4.8% on the session.
    • Blackrock Munivest Fund (NYSE:MVT) stock drifted down 1.03% on Thursday morning to hit a new 52-week low of $13.97.
    • Electric Last Mile Solns (NASDAQ:ELMS) stock achieved a new 52-week low on Thursday morning, hitting $2.25 and moving down 15.5%.
    • LDH Growth (NASDAQ:LDHA) stock drifted down 1.33% on Thursday morning to hit a new 52-week low of $9.62.
    • Tabula Rasa HealthCare (NASDAQ:TRHC) shares were 0.0% (flat) for the day, having made a 52-week low of $9.33.
    • MEI Pharma (NASDAQ:MEIP) shares set a new yearly low of $1.68 this morning. The stock was down 0.28% on the session.
    • Citizens (NYSE:CIA) stock drifted down 1.52% on Thursday morning to hit a new 52-week low of $4.53.
    • TPB Acquisition (NASDAQ:TPBA) shares reached a new 52-week low of $9.59 on Thursday morning, moving down 0.52%.
    • Alpine Immune Sciences (NASDAQ:ALPN) shares reached a new 52-week low of $7.36 on Thursday morning, moving down 1.99%.
    • Invesco Bond (NYSE:VBF) stock achieved a new 52-week low on Thursday morning, hitting $18.47 and moving down 0.51%.
    • Alexco Resource (AMEX:AXU) shares set a new 52-week low of $1.34. The stock traded down 2.86%.
    • Thayer Ventures (NASDAQ:TVAC) stock hit $9.28 on Thursday morning, setting a new 52-week low for a change of down 6.99%.
    • Finance of America (NYSE:FOA) shares fell to $3.41 on Thursday, setting a new 52-week low with a shift of down 5.77%.
    • Cyteir Therapeutics (NASDAQ:CYT) shares hit a yearly low of $5.13. The stock was 0.0% (flat) on the session.
    • 9 Meters Biopharma (NASDAQ:NMTR) stock broke to a new 52-week low of $0.70 on Thursday. Shares of the company traded down 0.97%.
    • NN (NASDAQ:NNBR) shares were down 2.79% for the day, having made a 52-week low of $3.48.
    • Quotient (NASDAQ:QTNT) shares hit a yearly low of $1.42. The stock was down 1.69% on the session.
    • Dirtt Environmental Solns (NASDAQ:DRTT) stock achieved a new 52-week low on Thursday morning, hitting $1.53 and moving down 1.27%.
    • Brooklyn (NASDAQ:BTX) shares fell to $2.37 on Thursday, setting a new 52-week low with a shift of down 0.2%.
    • Cadiz (NASDAQ:CDZI) stock hit $2.16 on Thursday morning, setting a new 52-week low for a change of down 6.41%.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares moved down 6.0% on Thursday to hit a new 52-week low of $4.76, drifting down 6.0%.
    • Luby's (NYSE:LUB) stock broke to a new 52-week low of $2.77 on Thursday. Shares of the company traded down 0.71%.
    • Geospace Technologies (NASDAQ:GEOS) stock set a new 52-week low of $6.25 on Thursday, moving up 0.25%.
    • Qilian Intl Hldg Gr (NASDAQ:QLI) shares reached a new 52-week low of $2.01 on Thursday morning, moving down 0.95%.
    • Kaleido Biosciences (NASDAQ:KLDO) stock achieved a new 52-week low on Thursday morning, hitting $1.68 and moving down 2.31%.
    • Lifevantage (NASDAQ:LFVN) stock broke to a new 52-week low of $5.20 on Thursday. Shares of the company traded down 0.75%.
    • mCloud Technologies (NASDAQ:MCLD) stock broke to a new 52-week low of $3.81 on Thursday. Shares of the company traded down 5.74%.
    • Assure Hldgs (NASDAQ:IONM) stock hit a yearly low of $3.96. The stock was down 9.17% for the day.
    • Redbox Entertainment (NASDAQ:RDBX) shares set a new 52-week low of $2.04. The stock traded down 17.84%.
    • CNS Pharmaceuticals (NASDAQ:CNSP) shares set a new yearly low of $0.48 this morning. The stock was down 1.82% on the session.
    • GBS (NASDAQ:GBS) shares made a new 52-week low of $0.85 on Thursday. The stock was down 3.14% for the day.
    • OceanPal (NASDAQ:OP) stock set a new 52-week low of $0.48 on Thursday, moving down 5.72%.
    • Palisade Bio (NASDAQ:PALI) shares set a new 52-week low of $0.81. The stock traded down 13.73%.
    • Ra Medical Systems (AMEX:RMED) stock dropped to a yearly low on Thursday of $0.77. Shares traded down 10.68%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares moved down 0.83% on Thursday to hit a new 52-week low of $1.12, drifting down 0.83%.

     

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ALPN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPN
    $AMPS
    $ANIK
    $AXU

    CompanyDatePrice TargetRatingAnalyst
    StoneCo Ltd.
    $STNE
    2/9/2026$22.00Buy
    BTIG Research
    Biogen Inc.
    $BIIB
    2/9/2026$194.00 → $228.00Buy
    H.C. Wainwright
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Iridium Communications Inc
    $IRDM
    1/16/2026$24.00Overweight → Equal-Weight
    Morgan Stanley
    Honeywell International Inc.
    $HON
    1/16/2026$255.00Neutral → Overweight
    Analyst
    More analyst ratings

    $ALPN
    $AMPS
    $ANIK
    $AXU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $ALPN
    $AMPS
    $ANIK
    $AXU
    SEC Filings

    View All

    SEC Form NT 10-Q filed by Geospace Technologies Corporation

    NT 10-Q - GEOSPACE TECHNOLOGIES CORP (0001001115) (Filer)

    2/9/26 12:02:25 PM ET
    $GEOS
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Biogen Inc.

    144 - BIOGEN INC. (0000875045) (Subject)

    2/9/26 10:14:40 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form N-CSRS filed by First Trust High Yield Opportunities 2027 Term Fund

    N-CSRS - FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND (0001810523) (Filer)

    2/9/26 9:34:44 AM ET
    $FTHY
    Investment Managers
    Finance

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wheeler Walter R. was granted 3,500 shares, increasing direct ownership by 2% to 172,006 units (SEC Form 4)

    4 - GEOSPACE TECHNOLOGIES CORP (0001001115) (Issuer)

    2/9/26 12:10:34 PM ET
    $GEOS
    Industrial Machinery/Components
    Industrials

    Director Miles Richard F was granted 3,500 shares, increasing direct ownership by 8% to 48,100 units (SEC Form 4)

    4 - GEOSPACE TECHNOLOGIES CORP (0001001115) (Issuer)

    2/9/26 12:09:51 PM ET
    $GEOS
    Industrial Machinery/Components
    Industrials

    Director Davis Thomas L was granted 3,500 shares, increasing direct ownership by 6% to 65,454 units (SEC Form 4)

    4 - GEOSPACE TECHNOLOGIES CORP (0001001115) (Issuer)

    2/9/26 12:09:13 PM ET
    $GEOS
    Industrial Machinery/Components
    Industrials

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium

    Virtual fireside chat scheduled for Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ET Access the webcast here Carlsbad, CA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer, will participate in a virtual fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium on Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ET. Th

    2/9/26 9:00:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Biologics License Application for Subcutaneous Formulation of "LEQEMBI®" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China

    TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen")) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of "LEQEMBI®" (brand name in China: "乐意保®", generic name: lecanemab), an anti-amyloid beta (Aβ) protofibril antibody, which was accepted in January 2026, has been designated for Priority Review by the National Medical Products Administration (NMPA) of China. The Priority Review and Approval Procedure was implemented

    2/8/26 9:00:00 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    /C O R R E C T I O N -- Maxeon Solar Technologies, Ltd./

    In the news release, Maxeon and Aiko Announce Patent Licensing Agreement, issued 06-Feb-2026 by Maxeon Solar Technologies, Ltd. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Maxeon and AIKO Announce Patent Licensing Agreement SINGAPORE, Feb. 6, 2026 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) and Shanghai AIKO Solar Energy Co., Ltd. (hereinafter referred to as "AIKO") today announced that the two parties have formally reached an agreement to license Maxeon's Back Contact (BC) solar cell and module patents.

    2/6/26 6:00:00 AM ET
    $MAXN
    Semiconductors
    Technology

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Lewis Darwin bought $5,265 worth of shares (805 units at $6.54), increasing direct ownership by 0.62% to 131,553 units (SEC Form 4)

    4 - Lifevantage Corp (0000849146) (Issuer)

    12/17/25 4:23:51 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on StoneCo with a new price target

    BTIG Research initiated coverage of StoneCo with a rating of Buy and set a new price target of $22.00

    2/9/26 7:01:42 AM ET
    $STNE
    EDP Services
    Technology

    H.C. Wainwright reiterated coverage on Biogen with a new price target

    H.C. Wainwright reiterated coverage of Biogen with a rating of Buy and set a new price target of $228.00 from $194.00 previously

    2/9/26 6:43:59 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Snap upgraded by Stifel with a new price target

    Stifel upgraded Snap from Sell to Hold and set a new price target of $5.50

    2/6/26 8:05:59 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Financials

    Live finance-specific insights

    View All

    Etsy to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    BROOKLYN, N.Y., Feb. 5, 2026 /PRNewswire/ -- Etsy, Inc. (NYSE:ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, plans to release its fourth quarter and full year 2025 financial results before the opening of the market on Thursday, February 19, 2026. The press release can be accessed on the Etsy Investor Relations website (investors.etsy.com). Etsy will also host a video webcast conference call to discuss those results at 8:30 a.m. Eastern Time on the same day, which will be live-streamed via the Company's Investor Relations website (investors.etsy.com) under the events section. Publishing research analys

    2/5/26 4:05:00 PM ET
    $ETSY
    Real Estate

    Viasat Releases Third Quarter Fiscal Year 2026 Financial Results

    CARLSBAD, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ:VSAT), a global leader in satellite communications, today published its third quarter fiscal year 2026 financial results. The letter to shareholders and accompanying webcast slides are available on the Investor Relations section of the company's website. Conference Call DetailsAs previously announced, Management will host a conference call to discuss the results today, Thursday, February 5, 2026 at 2:30 p.m. PT (5:30 p.m. ET). Access Information: Dial-in: (800) 715-9871 (U.S./Canada toll-free) or (646) 307-1963 (international)Conference ID: 3835630Live webcast: Available on Viasat's Investor Relations website. A r

    2/5/26 4:05:00 PM ET
    $VSAT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Geospace Technologies Reports First Quarter Fiscal Year 2026 Results

    Geospace Technologies Corporation (NASDAQ:GEOS) ("the "Company") today announced results for its first quarter ended December 31, 2025. For the three-months ended December 31, 2025, Geospace reported revenue of $25.6 million compared to revenue of $37.2 million for the comparable year-ago quarter. Net loss for the three-months ended December 31, 2025, was $9.8 million, or $(0.76) per diluted share, compared to net income of $8.4 million, or $0.65 per diluted share, for the quarter ended December 31, 2024. Management's Comments Richard J. ("Rich") Kelley, President and CEO of Geospace Technologies said, "The past year was not without its challenges many of which are reflected in our firs

    2/4/26 4:45:00 PM ET
    $GEOS
    Industrial Machinery/Components
    Industrials

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Leadership Updates

    Live Leadership Updates

    View All

    Dave O'Hara Joins Cadiz Board of Directors

    Former Microsoft Commercial CFO brings decades of experience in corporate finance and commercial strategy LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Cadiz, Inc. (NASDAQ:CDZI, the ", Company", )) announced today that Mr. Dave O'Hara, a senior finance executive with extensive experience in corporate finance, commercial strategy and large-scale growth initiatives, has joined the Company's Board of Directors. Mr. O'Hara spent more than 20 years at Microsoft in senior executive leadership roles, most recently serving as Executive Vice President and Chief Financial Officer of Microso

    2/4/26 9:46:00 AM ET
    $CDZI
    Water Supply
    Utilities

    Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors

    NEWTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its Board of Directors. Dr. Blanchard is an accomplished biotech and medtech CEO and board member with more than 30 years of experience building, scaling, and transforming public and private life sciences companies. Dr. Blanchard most recently served as President, CEO, and Director of Anika Therapeutics (NASDAQ:ANIK), where she led the successful implementat

    2/4/26 8:54:00 AM ET
    $ANIK
    Medical/Dental Instruments
    Health Care

    Stoneridge Announces Chief Financial Officer Departure

    NOVI, Mich., Feb. 2, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE:SRI) today announced that Chief Financial Officer and Treasurer, Matt Horvath, has resigned, effective March 31, 2026, to pursue an opportunity in a different industry sector. Horvath will continue to serve in his role through that date to support a smooth and orderly transition. Stoneridge's executive team and Board of Directors have initiated a comprehensive search to identify a Chief Financial Officer. Until a permanent replacement is appointed, Robert Hartman, Chief Accounting Officer, will work closely with

    2/2/26 5:20:00 PM ET
    $SRI
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ALPN
    $AMPS
    $ANIK
    $AXU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Skillz Inc.

    SC 13D/A - Skillz Inc. (0001801661) (Subject)

    12/12/24 4:01:36 PM ET
    $SKLZ
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities